Pfizer (PFE) Payables (2009 - 2026)
Pfizer's Payables was $4.07 billion in Q3 2026, down 19.0% from $5.02 billion a year earlier and down 42.1% from the prior quarter.
Analysis
Pfizer (PFE) Payables (2009 - 2026) Analysis & Trends
At the end of FY2025, Payables at Pfizer came in at $7.69 billion, down 4.8% from FY2024.
- Payables has now declined for three consecutive years, though with a five-year compound annual growth rate of 3.6% (FY2020 to FY2025).
- In earlier years, Payables was $8.07 billion in FY2024 (-11.1%), $9.08 billion in FY2023 (-0.3%), $9.11 billion in FY2022 (+16.4%) and $7.83 billion in FY2021 (+21.4%).
- The Q3 2026 figure marks the lowest quarterly Payables since Q1 2021.
- Compared with a year earlier, Payables has declined for five straight quarters, with an average decline of 8.3% over the last eight quarters.
- The best year-over-year quarter for Payables over five years was Q1 2022 (growth of 35.5%); the worst was Q3 2023 (a decline of 37.3%).
- Per Business Quant data, PFE's Payables in the three quarters before Q3 2026 was $7.03 billion (Q2 2026), $4.51 billion (Q1 2026) and $7.69 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 472.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 4.07 Bn |
| Jun 28, 2026 | 7.03 Bn |
| Mar 29, 2026 | 4.51 Bn |
| Dec 31, 2025 | 7.69 Bn |
| Sep 28, 2025 | 5.02 Bn |
| Jun 29, 2025 | 7.61 Bn |
| Mar 30, 2025 | 5.24 Bn |
| Dec 31, 2024 | 8.07 Bn |
| Sep 29, 2024 | 5.31 Bn |
| Jun 30, 2024 | 7.49 Bn |
| Mar 31, 2024 | 5.59 Bn |
| Dec 31, 2023 | 9.08 Bn |
| Oct 1, 2023 | 5.34 Bn |
| Jul 2, 2023 | 8.40 Bn |
| Apr 2, 2023 | 6.12 Bn |
| Dec 31, 2022 | 9.11 Bn |
| Oct 2, 2022 | 8.51 Bn |
| Jul 3, 2022 | 8.45 Bn |
| Apr 3, 2022 | 5.51 Bn |
| Dec 31, 2021 | 7.83 Bn |
API Access
Pfizer Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=PFE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();